ResMed, Inc., a leading player in the digital health and sleep solutions industry, is headquartered in the United States. Founded in 1989, the company has established itself as a pioneer in developing innovative products for the management of sleep apnoea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. ResMed's core offerings include advanced CPAP devices, cloud-connected software, and mobile applications that enhance patient care and adherence. Their commitment to integrating technology with healthcare sets them apart in the market. With a strong presence in North America, Europe, and Asia-Pacific, ResMed has achieved significant milestones, including numerous awards for product excellence and a robust market position as a trusted provider in respiratory care.
How does Resmed, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Resmed, Inc.'s score of 64 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ResMed, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of ResMed Inc., which may influence its climate commitments and reporting practices. Despite the lack of specific emissions data, ResMed is engaged in various climate initiatives. However, there are no documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges at this time. The company’s climate strategy may be informed by its parent organisation's policies, but specific details on these initiatives are not available. As a player in the healthcare technology sector, ResMed's climate commitments are crucial for aligning with industry standards and addressing the growing concerns around carbon emissions and sustainability. The absence of reported emissions data highlights an opportunity for ResMed to enhance transparency and set measurable targets in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 
| Scope 2 | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | - | - | - | - | - | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Resmed, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.